Court of Appeal Upholds Krka in Patent Infringement in Norway
Novo Mesto, 16 September - The Oslo Court of Appeal ruled that the Swedish subsidiary of the Slovenian pharma Krka does not violate the patent of the US pharma company MSD for manufacturing losartan, a drug used mainly to treat high blood pressure. The court thus confirmed the June 2008 decision by the District Court.
The rest of this news item is available to subscribers.
The news item consists of 450 characters (without spaces) or 99 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.